Rationale and design of the PREVENT-HIT study: A randomized, open-label pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis Academic Article uri icon

Overview

MeSH Major

  • Anticoagulants
  • Heparin
  • Pipecolic Acids
  • Thrombocytopenia
  • Thrombosis

abstract

  • The results from the PREVENT-HIT study should enhance understanding of the comparative clinical and economic utility of desirudin and argatroban in patients with HIT with or without thrombosis. ClinicalTrials.gov identifier: NCT00787332.

publication date

  • April 2010

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.clinthera.2010.04.012

PubMed ID

  • 20435232

Additional Document Info

start page

  • 626

end page

  • 36

volume

  • 32

number

  • 4